openPR Logo
Press release

Researchers Develop Microneedle Flu Vaccine for flu vaccination

07-22-2020 12:49 PM CET | Health & Medicine

Press release from: Coherent Market Insights

Microneedle Flu Vaccine

Microneedle Flu Vaccine

New research funding to develop commercially available micro needle flu vaccine, which would pace up the launch of these products. In 2015, the Georgia Institute of Technology and Micron Biomedical were awarded US$ 2.5 million in grants from the Bill & Melinda Gates Foundation to advance the development of dissolvable microneedle patches for polio immunization. This would also widen up the disease profile for which microneedle vaccine could be developed.

Growing instances of influenza flu pandemics in the U.S. would promote faster development of microneedle vaccines with reduced vaccination cost and no special need of storage conditions. According to Centers for Disease Control and Prevention, February 2018 report, during October 2017 and February 2018, clinical laboratories tested 666,493 specimens for influenza virus, 124,316 (18.7%) of which tested positive for influenza virus and 84.3% tested positive for influenza A virus.

Get PDF Brochure @ https://www.coherentmarketinsights.com/insight/request-pdf/2286

Key players in the global microneedle flu vaccine market are Micron Biomedical, Microdermics Inc., 3M Company, Inc., VaxInnate, and Vetter among others.

Microneedle Flu Vaccine Market Taxonomy

On the basis of vaccine type, the global microneedle flu vaccine market is segmented into:

Trivalent Flu Vaccine
Quadrivalent Flu Vaccine
On the basis of virus type, the global microneedle flu vaccine market is segmented into:

Influenza Virus Type- A
Influenza Virus Type- B
On the basis of geography, the global microneedle flu vaccine market is segmented into:

North America
Latin America
Europe
Asia Pacific
Middle East
Africa

Buy this Complete Business Report @ https://www.coherentmarketinsights.com/insight/buy-now/2286

Contact US

Mr.Shah
Phone: US +1-206-701-6702/UK +44-020 8133 4027
Email: sales@coherentmarketinsights.com

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Researchers Develop Microneedle Flu Vaccine for flu vaccination here

News-ID: 2094778 • Views:

More Releases from Coherent Market Insights

North America Bio-identical Hormones Market Outlook 2026-2033: Growth Drivers, Share, And Trends As Revealed In New Report | AbbVie Inc., Bayer AG., BioTE Medical, LLC
North America Bio-identical Hormones Market Outlook 2026-2033: Growth Drivers, S …
California, August 2026 - According to CMI, The North America bio-identical hormones market is expected to grow from USD 1,492.6 Mn in 2026 to USD 2,323.4 Mn by 2033, registering a compound annual growth rate (CAGR) of 6.5% from 2026 to 2033. The North America Bio-identical Hormones Market (2026-2033) research report delivers comprehensive global, regional, and country-level market intelligence, offering reliable forecasts, competitive benchmarking, and strategic business insights. The study
Europe, ASEAN, Middle East & Africa Nutraceuticals Market Outlook 2026-2033: Size, Demand Surge, Competitive Landscape & Strategic Opportunities | Nestl S.A., Danone S.A., DSM-Firmenich AG, Glanbia plc
Europe, ASEAN, Middle East & Africa Nutraceuticals Market Outlook 2026-2033: Siz …
According to CMI, The Europe, ASEAN, Middle East & Africa nutraceuticals market is expected to grow from USD 4,999.2 Mn in 2026 to USD 9,592.5 Mn by 2033, registering a compound annual growth rate (CAGR) of 9.8% from 2026 to 2033. The Europe, ASEAN, Middle East & Africa Nutraceuticals Market (2026-2033) research report delivers comprehensive global, regional, and country-level market intelligence, offering reliable forecasts, competitive benchmarking, and strategic business insights. The
Cardan Shaft Market Set to Surpass US$ 12.67 Billion by 2033, Expanding at 6.2% CAGR | 2026-2033 Forecast | Dana Incorporated, GKN Automotive, IFA Group, American Axle and Manufacturing
Cardan Shaft Market Set to Surpass US$ 12.67 Billion by 2033, Expanding at 6.2% …
California, August 2026 - According to CMI, The Global Cardan Shaft Market is estimated to be valued at USD 8.32 Bn in 2026 and is expected to reach USD 12.67 Bn by 2033, exhibiting a compound annual growth rate (CAGR) of 6.2% from 2026 to 2033. The Cardan Shaft Market (2026-2033) research report delivers comprehensive global, regional, and country-level market intelligence, offering reliable forecasts, competitive benchmarking, and strategic business
Probiotic Yeast Market Set for Rapid Growth and Trend by 2026-2033 Key Drivers And Analysis |Lallemand, Lesaffre, Angel Yeast, Biocodex
Probiotic Yeast Market Set for Rapid Growth and Trend by 2026-2033 Key Drivers A …
California, August 2026 - According to CMI, The Global Probiotic Yeast Market is estimated to be valued at USD 590.4 Mn in 2026 and is expected to reach USD 986.2 Mn by 2033, growing at a compound annual growth rate (CAGR) of 7.6% from 2026 to 2033. The Probiotic Yeast Market (2026-2033) research report delivers comprehensive global, regional, and country-level market intelligence, offering reliable forecasts, competitive benchmarking, and strategic business

All 5 Releases


More Releases for Flu

Bird Flu Market Safeguarding Flocks, Securing Health: The Bird Flu Challenge in …
Bird Flu Market to Record an Exponential CAGR by 2031 - Exclusive Report by InsightAce Analytic Pvt. Ltd. InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Bird Flu Market - (By Virus Type (H5N1, H7N9, H5N6, H5N8, H10N8, H9N2, Others), By Test Type (PCR Tests, ELISA Tests, Hemagglutination Assays, Virus Isolation Tests, Next Generation Sequencing, Others), By Treatment Type (Vaccines, Antiviral Medication, Immunomodulators, Others),
Microneedle Flu Vaccine Market New develop microneedle patch for flu vaccination
Drug delivery through the skin by transdermal patches has always been effective against viral infection and flu. Drug delivery through transdermal route is mainly effective due to passive diffusion of the drug and followed by drug development in transdermal delivery systems through different mechanism of action such as iontophorresis and sonophoresis. Moreover, pharmaceutical companies are focusing on development of micro-needle vaccines due to its immense utility in transdermal delivery of
Flu Vaccine (Influenza Vaccine) Market: A look into the future of the “Univers …
Latest update on Flu Vaccine (Influenza Vaccine) Market Analysis Report published with an SMI, the industry growth analysis, and Projection by 2021-2028. This report is highly predictive as it holds the overall market analysis of the topmost companies in the Flu Vaccine (Influenza Vaccine) industry. With the classified Flu Vaccine (Influenza Vaccine) market research based on various growing regions, this report provides leading players' portfolios along with sales, growth, market
Canine Flu Therapeutics Market 2019| To Develop Therapeutics For The Flu To Cont …
"Canine Flu Therapeutics Market: Global Industry Analysis 2013-2017 and Opportunity Assessment 2018-2028" is the latest addition to MarketResearchReports.Biz industry research reports collection. Canine flu (also known as dog flu) is a contagious respiratory disease in dogs mainly caused by Type A influenza/canine influenza virus. They are two various kinds of influenza viruses namely H3N8 virus and H3N2. Canine flu originated in horses, spread to dogs, and now spreads in between dogs
Benefits of a Workplace Flu Shot Program
It's that time of year again — we're at the start of the annual epidemic of seasonal influenza, which (in North America) peaks between now and April. As a business owner or office manager, you may well know the tremendous disruption that influenza, commonly known as the flu, can cause when it spreads from one employee to the next across your organization. According to a recent review of the scientific
Sunshine vitamin prevents flu
The vitamin D supply is one of the key factors for the outbreak and the course of influenza epidemics. Norwegian scientists have drawn this conclusion from a study on influenza epidemics, which has now been published in the specialist journal “International Journal of Infectious Diseases”. According to this study, with these influenza epidemics the infection and mortality rates increase with decreasing exposure to sunlight and thus, with decreasing vitamin D